Concepedia

Author

Keiko Hoshi

Showa Pharmaceutical University

Also Known As

K Hoshi, K. Hoshi, KEIKO HOSHI, Keiko HOSHI, Keiko Hoshi, Nobuko Futaki

86

Publications

1.3K

Citations

17

H-Index

97

Concepts

All Affiliations

Showa Pharmaceutical UniversitySt. Marianna University School of MedicineSocial Insurance Saitama Chuo HospitalSaitama Medical UniversityTokyo Women's Medical University
KH

About

Keiko Hoshi is an author at Showa Pharmaceutical University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

25

895

2

Health Sciences

3

3

44

3

Social Sciences

2

2

26

4

Engineering

1

1

180

5

Natural Sciences

1

1

37

Keiko Hoshi

×

29

Publications

1.1K

Citations

17

H-Index

YearCitations

Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs

Yutaka Mizushima, Toshiyuki Ikoma, Jyunzo Tanaka,

Journal of Controlled Release

2005

180

Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man

Yutaka Mizushima, Akira Yanagawa, Keiko Hoshi

Journal of Pharmacy and Pharmacology

1983

110

Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test.

Yutaka Mizushima, T Matsuda, Keiko Hoshi,

PubMed

1988

90

Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study

Masako Hara, Tohru Abe, Sachiko Sugawara,

Modern Rheumatology

2007

86

Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study

Masako Hara, Tohru Abe, Sachiko Sugawara,

Modern Rheumatology

2007

61

Health-related quality of life of unrelated bone marrow donors in Japan

Mina Nishimori, Yoshitsugu Yamada, Keiko Hoshi,

Blood

2002

60

Marked enhancement in antithrombotic activity of isocarbacyclin following its incorporation into lipid microspheres

Yutaka Mizushima, Rie Igarashi, Keiko Hoshi,

Prostaglandins

1987

48

Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.

Keiko Hoshi, Yutaka Mizushima, S Kiyokawa,

PubMed

1986

39

Long-term safety study of iguratimod in patients with rheumatoid arthritis

Masako Hara, Tohru Abe, Sachiko Sugawara,

Modern Rheumatology

2007

37

Dependence pH and proposed mechanism for aggregation of Alzheimer’s disease-related amyloid-β(1–42) protein

Shigeki Kobayashi, Yhuki Tanaka, Mituhiro Kiyono,

Journal of Molecular Structure

2015

37

Page 1